Esperion Therapeutics Inc Earnings

The next earnings date for Esperion Therapeutics Inc is February 24, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Esperion Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
02/24/2026$0.29

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Esperion Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/05/2025---$0-100.00%
08/05/2025---$-0.0285.71%
05/05/2025Before Market$-0.21-37.53%
02/25/2025Before Market$-0.1035.68%
11/05/2024Before Market$-0.1516.67%
08/12/2024Before Market$-0.33-83.33%
05/07/2024Before Market$0.34580.00%
02/27/2024Before Market$-0.50-4.17%
11/07/2023Before Market$-0.3713.95%
08/01/2023Before Market$-0.4624.59%
05/09/2023Before Market$-0.79-21.54%
02/21/2023Before Market$-0.769.52%
11/01/2022Before Market$-0.8111.96%
08/02/2022Before Market$-1.05-12.90%
05/03/2022Before Market$-0.9310.58%
02/22/2022Before Market$-1.7722.03%
11/02/2021Before Market$-2.626.43%
08/03/2021Before Market$-1.679.24%
05/04/2021After Market$-3.50-38.89%
02/23/2021After Market$-3.89-3.46%
11/02/2020After Market$-3.0710.76%
08/10/2020After Market$4.32152.63%
05/06/2020After Market$-2.8413.94%
02/27/2020Before Market$-2.2615.36%
11/06/2019Before Market$-2.52-29.23%
08/08/2019Before Market$-2.01-8.06%
05/08/2019Before Market$3.07314.86%
02/28/2019After Market$-2.24-57.75%
11/01/2018After Market$-1.86-14.11%
08/02/2018Before Market$-1.710.58%
05/02/2018Before Market$-1.73-10.90%
02/20/2018Before Market$-1.4419.55%
11/07/2017Before Market$-1.86-4.49%
08/08/2017Before Market$-1.92-19.25%
05/04/2017After Market$-1.80-26.76%
02/22/2017Before Market$-1.29-5.74%
11/03/2016After Market$-0.776.10%
08/04/2016After Market$-0.6220.51%
05/04/2016Before Market$-0.6512.16%
02/25/2016After Market$-0.587.94%
11/05/2015After Market$-0.575.00%
08/06/2015After Market$-0.555.17%
05/07/2015After Market$-0.56-16.67%
03/05/2015After Market$-0.4910.91%
11/10/2014After Market$-0.645.88%
08/12/2014---$-0.600.00%
05/12/2014---$-0.5117.74%
03/05/2014---$-0.63-26.00%
11/06/2013---$-0.3415.00%
08/12/2013---$-19.82---

More About Esperion Therapeutics Inc

Website
https://www.esperion.com
Country
USA
Full Time Employees
304

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

“Esperion Therapeutics Inc Earnings” Can Refer to the Esperion Therapeutics Inc Earnings Date

Some people say “Esperion Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Esperion Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Esperion Therapeutics Inc Stock on the Earnings Date

If you own Esperion Therapeutics Inc stock (ESPR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Esperion Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Esperion Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Esperion Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Esperion Therapeutics Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.